ADecade of Progress - NASPGHAN · Pediatric Gastroenterology, Hepatology and Nutrition is to:...
Transcript of ADecade of Progress - NASPGHAN · Pediatric Gastroenterology, Hepatology and Nutrition is to:...
November 13–15, 2008
Sheraton San Diego Hotel & Marina San Diego, CA
SPECIAL SINGLE TOPIC SYMPOSIUM
THE GUT MICROBIOME IN DEVELOPMENT, HEALTH AND DISEASE
November 12, 2008
THE NASPGHAN–CDHNF PARTNERSHIP:A CLINICAL & SCIENTIFIC CONFERENCE
A Decade of Progress
REGISTRATION BROCHURE
And
Dear Colleague:
We invite you to attend “The NASPGHAN–CDHNF Partnership: A Decade of Progress” meeting to be held at the beautiful SheratonSan Diego Hotel & Marina in San Diego, California from Thursday through Saturday November 13th–15th, 2008. The planning committee,including B Li, Brent Polk, Laurie Fishman, John Pohl, Steven Schwarz, Alan Leichtner and Karen Murray, has put together an outstandingprogram that will engage the interest of clinicians, academics, and trainees alike.
The meeting will be preceded by a special, NIH–funded, one day symposium entitled “The Gut Microbiome in Development, Healthand Disease” to be held on Wednesday, November 12th. A host of international experts in the field will review biologic and technologicadvances in the rapidly evolving field of the intestinal microbiome, how it is acquired in newborns, the mechanisms by which it interactswith the mucosal immune system, its relation to specific diseases (inflammatory bowel disease, obesity), and its modification by pre–,pro– and antibiotics. The intent of the symposium is to provide interested professionals (including young investigators and trainees)with a state–of–the–art overview of this exciting and rapidly involving discipline.
The NASPGHAN–CDHNF meeting will begin on Thursday, November 13th with a “Challenges in Nutrition” Postgraduate Course,focused entirely on pediatric nutrition. The five modules include: Parenteral Nutrition, Obesity and the Gastroenterologist, Vitaminand Minerals Potpourri, Allergy Prevention and Diet, and Enteral Feeding. The talks will be concise and will be followed by rapid–firequestions. Participants will have the option to purchase tickets to eight case-based “Learning Lunches”, a popular learning format ledby Postgraduate Course speakers.
The main portion of the NASPGHAN–CDHNF meeting begins the evening of Thursday, November 13th with a poster session and reception and concludes Saturday evening with a celebration dinner. An outstanding and diverse faculty has been assembled for theplenary session (CDHNF highlights, career vignettes, state-of-the-art, year-in-review formats), 5 research abstract oral presentationsand 3 poster sessions (covering basic science, clinical investigation, and clinical practice vignettes), 10 concurrent clinical modules, and new case-based Clinical Challenge Luncheons (with pre– and post– tests). The clinical modules have been redesigned to include a 30–minute case–based panel (and audience) discussion.
Indeed, this year’s NASPGHAN–CDHNF Partnership Meeting will be a fabulous event, sure to meet the multiple clinical, research andtraining needs of our diverse membership.
We look forward to seeing you in sunny San Diego!
Cordially,
John A. Barnard, MD William F. Balistreri, MD B Li, MDPresident, NASPGHAN President, CDHNF President-Elect, NASPGHANColumbus, Ohio Cincinnati, OH Milwaukee, Wisconsin
ORGANIZING COMMITTEEWilliam Balistreri, MD (CDHNF President) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . CDHNF Anniversary
John Barnard, MD (NASPGHAN President) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Program Advisor
Laurie Fishman, MD (Chair, Professional Education Committee) . . . . . . . . . . . . . . . . . . . . NASPGHAN Postgraduate Course, Co-Director
Alan Leichtner, MD (Chair, Training Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Teaching and Tomorrow Program
Ivor Hill, MD (NASPGHAN Secretary-Treasurer) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Meeting Budget
Nicola Jones, MD, PhD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Single topic symposium, Co-Chair
B Li, MD (NASPGHAN President-Elect) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Program Committee Chair
Jenifer Lightdale, MD (Chair, Endoscopy Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Video Learning Center
Karen Murray, MD (Chair, Professional Development Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Professional Development Program
John Pohl, MD (Professional Education Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . NASPGHAN Postgraduate Course, Co-Director
D. Brent Polk, MD (Chair, Research Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Scientific Program
Steven Schwarz, MD (Chair, Clinical Care & Quality Committee) . . . Clinical Practice Forum, Clinical Vignette Posters, Billing & Coding
Philip Tarr, MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Single topic symposium – Co-chair
Menno Verhave, MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . CDHNF Anniversary
NASPGHAN National Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Meeting oversight, logistics, planning
HOTEL INFORMATION
SHERATON SAN DIEGO HOTEL & MARINA–1380 Harbor Island DriveSan Diego, CA 92101
PHONE: 619-291-2900
FAX: 619-692-2337
HOTEL RESERVATIONS
HOTEL RESERVATION DEADLINE –
September 22, 2008
SINGLE/DOUBLE – $209.00Special NASPGHAN room rate. Applicable taxes will beadded. ( US rate subject to change based on currentexchange rates)
CHECK-IN TIME – 3:00 pm
CHECKOUT TIME – 12:00 noonTo obtain the special NASPGHAN room rates,register ONLINE via the NASPGHAN website.
www.naspghan.org
2
REGISTRATION
PRE-REGISTRATION DEADLINE –October 14, 2008
�Register by mail, fax or the Internet.
�Visit (www.naspghan.org) to register online.
�Alternately, mail or fax the registration form located on page 16 of this brochure to the NASPGHAN National Office.
�Meeting confirmations, tickets and badges will be mailed 3 weeks prior to the meeting.
�After October 14, all fees will increase by $50 per category.
MEETING OBJECTIVES AND CME INFORMATION
MISSION STATEMENT –
The education mission of the North American Society forPediatric Gastroenterology, Hepatology and Nutrition is to:
�Advance understanding of normal development, physiology and pathophysiology of diseases of the gastrointestinal tract, liver and nutrition in children.
�Improve professional competence, quality of care, and patient outcomes by disseminating knowledge through scientific meetings, professional and public education.
Our activities, education, and interventions will strive touse Adult Learning Methods (ALM) designed to improvecompetence, practice performance, and patient outcomes in measurable ways. These educational activities will betargeted to pediatric gastroenterologists, physicians withan expertise in pediatric gastroenterology, hepatology andnutrition, subspecialty fellows in pediatric gastroenterology,and nurses specializing in pediatric gastroenterology, hepatology and nutrition.
CME INFORMATION
NASPGHAN is accredited by the Accreditation Council forContinuing Medical Education to provide continuing medicaleducation for physicians. This activity has been approved forAMA PRA Category 1 Credit(s)TM. Physicians should only claimcredit commensurate with the extent of their participation inthe activity.
FACULTY DISCLOSUREIn order to ensure independence, objectivity and scientificrigor in all activities and in accordance with the ACCME,ANCC and ACPE Standards for Commercial Support; allthose in a position to control the content of an educationalactivity are required to disclose their relevant financial relationships. This includes indicating that one has nothing to disclose. Disclosure information will be distributed to the activity attendees.
AMERICANS WITH DISABILITIES ACTIn compliance with the Americans with Disabilities Act of1990, NASPGHAN will make all reasonable effort to accommodate persons with disabilities. ContactNASPGHAN in order to make arrangements.
NASPGHAN NATIONAL OFFICE
PO BOX 6
FLOURTOWN, PA 19031
TELEPHONE: 215.233.0808
FAX: 215.233.3918
EMAIL: [email protected]
WEBSITE: WWW.NASPGHAN.ORG
3
Single Topic ConferenceTHE GUT MICROBIOME IN DEVELOPMENT, HEALTH AND DISEASE
WEDNESDAY, NOVEMBER 12, 2008
COURSE DIRECTORS: NICOLA JONES, MD, PHD & PHIL TARR, MDNowhere in human biology are basic concepts changing more rapidly than in our understanding of the human microbiome. Compellingevidence indicates that the gut microbiota play extensive roles in normal development, health and disease. In few areas of science haveso many different worthwhile opportunities for study appeared simultaneously. Therefore, the aims of this meeting are to outline theclinical importance of the gastrointestinal microbiome and to teach young investigators the skills to move this burgeoning field forward.
LEARNING OBJECTIVES:Review the latest opportunities to study the gut microbiomePresent evidence for the role of the intestinal microbiota in the developing immune system and various intestinal & non-intestinal diseases
INTRODUCTION TO THE MICROBIOME
�
�
4
8:00am–8:15am IntroductionNicola Jones, MD, PhD, The Hospital for Sick Children, Toronto and Phil Tarr, MD, Washington University, St. Louis
8:15am–9:00am Understanding Complex MicrofloraClara Long Davis, PhD, Stanford University
9:00am–9:30am The Human Microbiome Project: Preparing for the Challenges & OpportunitiesElaine J Mardis, PhD, Genome Sequencing Center, Washington University, St. Louis
9:30am–10:00am The Canadian Microbiome Project
10:00am–10:30am Break
THE MICROFLORA IN INFLAMMATORY BOWEL DISEASES
10:30am–11:15am Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune SystemWendy Garrett, MD, PhD, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard School of Public Health
11:15am–12:00pm The Intestinal Microflora in Crohn’s DiseaseDaniel Frank, PhD, University of Colorado
12:00pm–12:30pm Question & Answer Session / Discussion Period / Future Directions
12:30pm–2:00pm Lunch / Breakout Sessions for Young Investigators Focusing on Training and Career Development OpportunitiesFaculty panel
THE ROLE OF THE MICROFLORA IN DEVELOPMENT
2:00pm–3:00pm KEYNOTE SPEAKER –The Role of the Human Childhood Intestinal Microbiota in Asthma and other Allergic DisordersBengt Björkstén, MD, PhD, Karolinska Institute
3:00pm–3:45pm Microbes and the Newborn IntestineAllan Walker, MD, Massachusetts General Hospital and Harvard Medical School
3:45pm–4:15pm Question & Answer Session / Discussion Period / Future Directions
4:15pm–4:30pm Break
4:30pm–4:45pm The Role of the Gut Microbiota in Enteric NeurobiologySteven M Collins, MBBS, McMaster University, Hamilton, Ontario, Canada
4:45pm–5:15pm The Role of Bacteroides Fragilis Polysaccharide in Modulating Vertebrate Immune ResponseSarkis K Mazmanian, PhD, California Institute of Technology
5:15pm–5:45pm Question & Answer Session / Discussion Period / Future Directions
5:45pm Research Support for the Microbiome
Wrap Up / Final Agenda
�
�
�
�
�
�
5
Challenges inNutrition:A Postgraduate CourseTHE NASPGHAN-CDHNF PARTNERSHIP: A DECADE OF PROGRESS
THURSDAY, NOVEMBER 13, 2008
8:00am–8:10am INTRODUCTION
8:10am–9:10am MODULE A – REDUCING THE COMPLICATIONS OF PARENTERAL NUTRITION Moderators: John Pohl, MD and Dana Ursea, MD
Long chain omega–3 fatty acid (LCOFA): Does it prevent cholestasis?Beth Carter, MD, Texas Children’s Hospital
Learning Objectives: 1. Present the evidence that LCOFA reduces cholestasis2. Identify the mechanisms whereby LCOFA may work3. Discuss the approval status of LCOFA and other fish-oil based lipid formulations
On the line: Preventing catheter sepsisJeffrey Rudolph, MD, Cincinnati Children's Hospital Medical Center
Learning Objectives: 1. Discuss the mechanisms of line sepsis – why infection with gut bacteria?2. Discuss techniques of preventing line sepsis, including ethanol and antibiotic locks3. Characterize timing of line placement and line type to prevent line-related sepsis
Anticipating long-term nutritional complications of TPNMaria Mascarenhas, MD, Children’s Hospital of Philadelphia
Learning Objectives: 1. Characterize micronutrient deficiencies in children receiving parenteral nutrition2. Discuss medical complications of the lack of lipid emulsions or essential fatty acids3. Identify the need for iron infusions in children receiving parenteral nutrition
9:10am–9:20am RAPID–FIRE QUESTIONS
9:20am–9:40am BREAK
9:40am–10:40am MODULE B – EFFECTS OF ENTERAL FEEDINGS ON THE INFANT GUTModerators: Laurie Fishman, MD and Michelle Pietzak, MD
Does formula composition change motility?Samuel Nurko, MD, Children’s Hospital, Boston
Learning Objectives: 1. Discuss formula type (casein and whey-based, soy, hydrolyzed) and its effect on motility2. Discuss osmotic load in formula and the effect on motility3. Discuss formula lipid content and its effect on motility
How does enteral feeding affect the intestinal microbiomeEytan Wine, MD, The Hospital for Sick Children, Toronto
Learning Objectives: 1. Outline the acquisition of the normal infant intestinal microflora2. Discuss how macronutrients affect the microflora3. Discuss implications of altered microflora on later health
Are you what you eat? The effect of infant diet on later health Susannah Huh, MD, Children’s Hospital, Boston
Learning Objectives: 1. Discuss association between infant growth and later health outcomes, including
obesity, cardiovascular disease, and cognition2. Discuss association between infant feeding practices and later health outcomes3. Discuss how pregnancy and infant dietary composition may affect lifelong health
10:40am–10:50am RAPID–FIRE QUESTIONS
10:50am–11:00am BREAK
11:00am–12:00pm MODULE C – OBESITY AND THE GASTROENTEROLOGISTModerators: Sandeep Gupta, MD and John Pohl, MD
The role of genes and hormones Matthias Tschoep, PhD, University of Cincinnati
Learning Objectives: 1. Describe what is new in the research front on the genetics of obesity2. Discuss the interactions between obesity-related hormones (leptin, ghrelin)3. Describe the effect of gastric bypass on obesity-related hormones
Managing metabolic syndrome Stavra Xanthakos, MD, Cincinnati Children's Hospital Medical Center
Learning Objectives: 1. Define the metabolic syndrome2. Identify associated gastrointestinal complications, including hepatic disease3. Describe medications used for treatment
How does obesity and non-alcoholic fatty liver disease (NAFLD) affect chronic liver disease?Simon Horslen, MD, Seattle Children’s Hospital
Learning Objectives: 1. Describe the effect of NAFLD on chronic viral hepatitis2. Characterize the effect of NAFLD on autoimmune hepatitis3. Identify other hepatic diseases that can mimic NAFLD
12:00pm–12:10pm RAPID–FIRE QUESTIONS
12:10pm–1:40pm NUTRITION LEARNING LUNCHES (separate registration required)
LONG CHAIN OMEGA–3 FATTY ACIDS AND CHOLESTASIS /LONG TERM COMPLICATIONS OF TPNModerator: Dana Ursea, MDBeth Carter, MD and Maria Mascarenhas, MD
CENTRAL LINE SEPSIS PREVENTION / IRON AND INFLAMMATIONModerator: David Easley, MDJeffrey Rudolph, MD and Richard Grand, MD
VITAMIN D AND INFLAMMATIONModerator: Jane Balint, MDFrancisco Sylvester, MD
OBESITY GENES AND HORMONES / METABOLIC SYNDROMEModerator: Sandeep Gupta, MDMatthias Tschoep, PhD and Stavra Xanthakos, MD
OBESITY AND CHRONIC LIVER DISEASE / VITAMIN E AND LIVER DISEASEModerator: John Pohl, MDSimon Horslen, MD and Ronald Sokol, MD
DIET AND ALLERGIC DISEASE PREVENTION / FETAL ORIGINS OF DISEASEModerator: Kathy Chen, MDFrank Greer, MD and Susanna Huh, MD, MPH
FOOD LABELING / ELIMINATION DIETSModerator: Kevin Kelly, MDAmir Kagawalla, MD, and Vanessa Ludlow, RD
FORMULA COMPOSITION AND MOTILITY / INFANT MICROBIOMEModerator: Daniel Gelfond, MDSamuel Nurko, MD, MPH and Eytan Wine, MD
�
�
�
1
2
3
4
5
6
7
8
6 Thursday, November 13, 2008 continued . . .
�
�
�
�
�
�
7
1:40pm–2:40pm MODULE D–VITAMIN AND MINERAL POTPOURRIModerators: John Pohl, MD and Jane Balint, MD
Does inflammation interfere with iron?Richard Grand, MD, Children’s Hospital, Boston
Learning Objectives: 1. Review the physiology of iron homeostasis (including role of hepcidin)2. Describe the changes in iron homeostasis in states of inflammation (e.g. IBD)3. Characterize treatment strategies, including intravenous iron infusion
Vitamin D – It’s not just for the bonesFrancisco Sylvester, MD, Connecticut Children’s Medical Center
Learning Objectives: 1. Review vitamin D metabolism and causes of deficiency2. Describe the role of vitamin D chemoprophylaxis in colon cancer3. Describe the role of vitamin D in inflammation4. Describe the relationship of vitamin D to insulin metabolism in type II diabetes mellitus
Can vitamin E help in liver disease?Ronald J. Sokol, MD, The Children’s Hospital, Denver
Learning Objectives: 1. Discuss the use of vitamin E in the treatment of childhood NAFLD2. Review vitamin E metabolism and clinical manifestations of deficiency3. Describe supplementation in cystic fibrosis, steatohepatitis, and � lipoproteinemia
2:40pm–2:50pm RAPID–FIRE QUESTIONS
2:50pm–3:10pm BREAK
3:10pm–4:10pm MODULE E – ALLERGY PREVENTION AND DIETModerators: Laurie Fishman, MD and Kevin Kelly, MD
Can diet prevent food allergies?Frank Greer, MD, University of Wisconsin
Learning Objectives: 1. Identify infants at high risk for the development of food allergies2. Characterize evidence for the hygiene theory and for use of pre-/probiotics3. Describe the delayed timing of food introduction to prevent food-related allergies
The successful elimination diet for eosinophilic esophagitis (EE)Amir Kagalwalla, MD, University of Illinois, Chicago
Learning Objectives: 1. Discuss the merits of dietary treatment in preventing sequelae such as fibrosis in EE2. Compare directed vs. empiric food elimination diet to diagnose and treat food allergies3. Identify the psychological and nutritional effects of the elimination diet
The food-labeling act and its effect on food-restricted diets Vanessa Ludlow, RD, Children’s Hospital, Boston
Learning Objectives: 1. Describe the purity of gluten-free foods in the U.S. in relationship to threshold2. Characterize food labeling and the food-labeling act3. Describe the level purity of cow milk antigen-free food in relationship to threshold
4:10pm–4:20pm RAPID–FIRE QUESTIONS
4:20pm–4:30pm WRAP–UP / ADJOURN
8
A Clinical & Scientific ConferenceTHE NASPGHAN–CDHNF PARTNERSHIP: A Decade of Progress
Friday, November 14, 2008 continued . . .
THURSDAY, NOVEMBER 13, 2008
5:00pm–7:00pm POSTER SESSION I / OPENING RECEPTION
FRIDAY, NOVEMBER 14, 2008
8:00am–9:50am NASPGHAN/CDHNF PLENARY SESSION IModerators: William Balistreri, MD and John Barnard, MD
8:00am WELCOMEJohn Barnard, MD
8:05am CDHNF: A DECADE OF PROGRESSGeorge Ferry, MD, Baylor College of MedicinePast President, CDHNF
8:20am CDHNF INVESTIGATOR AWARDS / CAREER VIGNETTESDavid Rudnick, MD, Washington University, St. LouisNeera Gupta, MD, University of California, San Francisco
8:50am ABSTRACT PRESENTATIONS
9:20am BASIC SCIENCE YEAR-IN-REVIEW Eric Sibley, MD, Stanford UniversityEditor, Journal of Pediatric Gastroenterology and Nutrition
9:50am–10:30am BREAK
10:30am–12:00pm NASPGHAN/CDHNF PLENARY SESSION IIModerators: D. Brent Polk, MD and B Li, MD
10:30am MEETING UPDATEB Li, MD
10:35am ABSTRACT PRESENTATIONS
11:05am IMPROVING OUTCOMES VIA MAINTENANCE OF CERTIFICATION–FROM THE AMERICAN BOARD OF PEDIATRICS GASTROENTEROLOGY SUBBOARDChris Dickinson, MD, University of Michigan
11:20am CDHNF DRIVING THE AAP eQIPP MODULE ON GERDJenifer Lightdale, MD, Children’s Hospital, Boston
11:35am CLINICAL SCIENCE YEAR-IN-REVIEW William Balistreri, MD, Cincinnati Children’s Hospital Medical CenterEditor, Journal of Pediatrics
12:00pm–2:00pm POSTER SESSION II
1
2
3
�
�
�
�
�
�
�
9 Friday, November 14, 2008 continued . . .
2:00pm–3:30pm CONCURRENT SESSION I
CONTROVERSIES IN TREATMENT OF CHRONIC HEPATITIS Moderators: Jean Molleston, MD and Latifa Yeung, MD
Management of hepatitis B: Who, how and with what? Michael Narkewicz, MD, The Children’s Hospital, Denver
Learning Objectives: 1. Discuss the current indications for treatment of chronic hepatitis B2. Describe the diagnostic approach to drug-resistant hepatitis B3. Discuss current therapy (including multi-drug) for treatment of hepatitis B
Management of hepatitis C: What you can see and what you don’t! Kathleen Schwarz, MD, Johns Hopkins University
Learning Objectives: 1. Discuss the current indications for treatment of hepatitis C in children2. Describe current treatment regimens for hepatitis C infection3. Review the potential treatment side effects
Infectious hepatitis – non A-E: How the unalphabetized attack Karen Murray, MD, Children’s Hospital and Regional Medical Center, Seattle
Learning Objectives: 1. Discuss the epidemiology of non A-E viral hepatitis in neonates 2. Discuss the epidemiology of non A-E viral hepatitis in the adolescent3. Describe the epidemiology of non A-E hepatitis in acute liver failure
AUTOIMMUNITY AND THE DIGESTIVE TRACTModerators: Wallace Crandall, MD and James Lopez, MD
Autoimmunity: PathophysiologyTroy Torgerson, MD, Children’s Regional Medical Center, Seattle
Learning Objectives: 1. Provide the current diagnostic criteria for autoimmunity in general2. Describe the genetic basis for autoimmune enteropathy and IPEX3. Describe the current testing (including genetic) for various autoimmune enteropathies
Autoimmune enteropathy: Clinical presentation and treatment Harland Winter, MD, Massachusetts General Hospital for Children
Learning Objectives: 1. Review the clinical presentation of autoimmune enteropathies2. Describe the utility of serological testing3. Characterize the current treatment regimens for this disorder
Autoimmune hepatitis: Update Deborah Freese MD, Mayo Clinic
Learning Objectives: 1. Discuss the incidence, pathophysiology, and diagnosis of type l and type ll
autoimmune hepatitis and the overlap syndromes2. Review new therapeutic options for treatment in children3. Identify treatment options for recurrence post liver transplantation
RESEARCH INTEREST GROUP & ORAL ABSTRACT PRESENTATION
STATE-OF-THE-ART LECTURES
Food Allergy, Probiotics and Gastrointestinal EosinophilaBengt Björkstén, MD, PhD, Karolinska Institute and Glenn Furuta, MD, The Children’s Hospital, Denver, CO
1
2
3
1
2
�
�
�
�
�
�
10
3:30pm–5:00pm CONCURRENT SESSION II
NEW CLINICAL UPDATESModerators: Ann Scheimann, MD and John Thompson, MD
Eosinophilic esophagitis (EE): TIGERS Consensus 2007 Chris Liacouras, MD, Children’s Hospital of Philadelphia
Learning Objectives: 1. Review the consensus re: histologic criteria for diagnosis of EE 2. Discuss the food-elimination diet and its practical aspects3. Compare the efficacy of various steroid preparations (including treatment of relapses)
Celiac disease – What’s new? Ed Hoffenberg, MD, The Children’s Hospital, Denver
Learning Objectives: 1. Discuss a new celiac disease test : antibodies to deamidated gliadin peptide2. Discuss what to do with the diabetic child with evidence of celiac disease3. Review new food labeling laws
NAFLD: A supersized liver Miriam Vos, MD, Emory University, Atlanta
Learning Objectives: 1. Discuss histologic and radiographic diagnostic criteria2. Review the treatment options (metformin, UDCA and vitamin E)3. Identify the effect of bariatric surgery on prevention and/or reversal of NAFLD
ADVANCED ENDOSCOPIC TECHNIQUESModerators: Marsha Kay, MD and Petar Mamula, MD
Capsule endoscopy: State-of-the-art in childrenStan Cohen, MD, Children’s Center for Digestive Healthcare, Atlanta
Learning Objectives: 1. Review capsule endoscopy procedures and competency requirements2. Describe the current indications for capsule endoscopy in children3. Identify new types of capsule endoscopy and future pediatric uses
Endoscopic Botox in pediatrics: Not just for the 40+ crowd Samuel Nurko, MD, MPH, Children’s Hospital, Boston
Learning Objectives: 1. Describe the mechanism, duration of action and technique of injection of botulinum toxin2. Review the technique and results for cricopharyngeal achalasia, achalasia and pyloric
dysfunction3. Review the technique and results for anal achalasia and Hirschsprung’s disease
Single and double-balloon enteroscopy: Are they ready for prime time? Bradley Barth, MD, Children’s Medical Center of Dallas
Learning Objectives: 1. Discuss emerging techniques in enteroscopy2. Review current clinical trials3. Identify potential clinical indications in pediatrics and limitations of technique and
equipment
ORAL ABSTRACT PRESENTATIONS
6:00pm TRAINING PROGRAM DIRECTORS’ MEETING
PRACTIONERS’ FORUM
1
2
3
11
�
�
�
�
�
�
Saturday, November 14, 2008 continued . . .
SATURDAY, NOVEMBER 15, 2008
7:00am–9:00am POSTER SESSION III/CONTINENTAL BREAKFAST
8:30am–10:00am CONCURRENT SESSION III
NEW NASPGHAN GUIDELINES: THE CURRENT STATUSModerators: Barbara Kaplan, MD and Steven Schwarz, MD
Pediatric GERD Colin Rudolph, MD, PhD, Children’s Hospital of Wisconsin
Learning Objectives: 1. To review new evidence-based recommendations for the diagnosis of pediatric GERD 2. To describe changes in symptom-based diagnostic and management approaches for
pediatric GERD
3. To discuss changes in practice recommended in new pediatric GERD guidelines
H. pylori infection in children Nicola Jones, MD, PhD, The Hospital for Sick Children, Toronto
Learning Objectives: 1. Identify revised consensus on diagnostic testing for H. pylori infection2. Characterize antibiotic resistance and use of H. pylori antibiotic sensitivity testing3. Review the current combined antibiotic and PPI treatment regimens
Cyclic vomiting syndrome B Li, MD, Children’s Hospital of Wisconsin Gisela Chelimsky, MD, Rainbow Babies & Children’s Hospital
Learning Objectives: 1. Identify revised definition of cyclic vomiting syndrome 2. Discuss consensus on the diagnostic approach to and disorders that mimic CVS3. Review new therapeutic options including abortive and prophylactic approaches
MANAGEMENT OF PORTAL HYPERTENSION Moderators: Frederick Watanabe, MD and Harpreet Pall, MD
Complications of portal hypertension Vicky Ng, MD, The Hospital for Sick Children, Toronto
Learning Objectives: 1. Provide a definition of portal hypertension (including Doppler imaging)2. Describe mediators involved in the pathogenesis of portal hypertension3. Characterize the clinical manifestations of portal hypertension
Medical management of varicesSimon Ling, MD, The Hospital for Sick Children, Toronto
Learning Objectives: 1. Review strategies for the identification of children at high risk of varices2. Review the prophylaxis of variceal hemorrhage3. Review the medical treatment of children with acute variceal hemorrhage
Non-medical management of portal hypertension Naveen Mittal, MD, Children’s Medical Center, Dallas
Learning Objectives: 1. Review current shunting techniques used to treat portal hypertension2. Management of post-shunt complications3. Review role of transplant in portal hypertension
ORAL ABSTRACT PRESENTATIONS
1
2
3
12
�
�
�
�
�
�
Saturday, November 14, 2008 continued . . .
10:30am–12:00pm CONCURRENT SESSION IV
AERODIGESTIVE APPROACHES TO DYSPHAGIA AND ASPIRATIONModerators: Colin Rudolph, MD, PhD and Khalid Khan, MD
The evaluation and management of children with feeding disorders Richard Noel, MD, PhD, Medical College of Wisconsin
Learning Objectives: 1. Review normal progression of swallowing skill acquisition / changes in anatomy2. Review assessment of swallowing in infants and young children with dysphagia3. Review video swallow study – no penetration or aspiration 4. Discuss management of this child in the context of his/her therapies, feeding skills,
growth, and respiratory issues
Evaluation and management of pulmonary complications of feeding and/or gastroesophageal refluxAjay Kaul, MD, Cincinnati Children’s Hospital Medical Center
Learning Objectives: 1. Discuss differential diagnosis2. Review and discuss investigations for silent aspiration, decreased pharyngeal and vocal
fold sensation and aspiration, role of bronchoscopy, impedance, high resolution CT3. Management from gastrointestinal perspective: dietary changes, oral motor therapy,
acid blockade, gastrostomy tube
Evaluation and management of a child with anatomic abnormalities of the aerodigestive tractRachel Rosen, MD, Children’s Hospital, Boston
Learning Objectives: 1. Discuss airway anatomic anomalies (laryngeal cleft/TEF, paralyzed vocal cord)2. Identify gastrointestinal anatomic anomalies (esophageal atresia/TEF, gastric
pull-up procedure)3. Describe the clinical impact of GER(D), eosinophilic esophagitis, vomiting, feeding
intolerance4. Identify ENT concerns regarding above
POST-TRANSPLANT GASTROINTESTINAL COMPLICATIONS Moderators: Daniel Kamin, MD and Philip Rosenthal, MD
The GI manifestations of graft-versus-host disease (GVHD) William Berquist, MD, Lucile Packard Children’s Hospital, Palo Alto
Learning Objectives: 1. Review the causes, time course and clinical presentation of GVHD2. Describe the endoscopic and histologic manifestations and treatment3. Describe extraintestinal manifestations of GVHD (hepatic) and treatment
Post-transplant lymphoproliferative disease (PTLD): An updateEstella Alonso, MD, Children’s Memorial Hospital, Chicago
Learning Objectives: 1. Review PTLD and its changing incidence and clinical presentations in children2. Describe the radiographic, biopsy, and PCR testing to confirm PTLD3. Discuss the treatment options for PTLD
Intestinal transplant and gut motilitySamuel Kocoshis, MD, Cincinnati Children’s Hospital Medical Center
Learning Objectives: 1. Review the changes in motility in the transplanted and rejected intestine2. Describe testing modalities used to confirm dysmotility3. Discuss available treatment options for dysmotility in transplanted bowel (including
treatment of sepsis)
ORAL ABSTRACT PRESENTATIONS
1
2
3
4
5
6
7
8
9
10
13 Saturday, November 14, 2008 continued . . .
12:00pm–1:30pm NEW CLINICAL CHALLENGE LUNCHEONS (REGISTRATION REQUIRED)
These are new interactive, case-based luncheons – participants may submit a case in advancedirectly to the moderators. The format will involve: a pre-test and post-test (same) – withaggregate results provided to participants, cover 4–6 case scenarios, and provide an in–depthdiscussion of evidence base areas of controversy (e.g. pro vs. con), clinical reasoning and decision-making, and a rationale approach in the absence of definitive evidence or consensus guidelines.
ALLERGIC BOWEL DISEASE Moderator: Qian Yuan, MD, PhDJohn Kerner, MD, Lucile Packard Children’s Hospital, Palo AltoSandeep Gupta, MD, Riley Children’s Hospital, Indianapolis
THERAPEUTIC APPROACHES TO IRRITABLE BOWEL SYNDROME: WE FEEL YOUR PAIN Moderator: Christopher Jolley, MDAdrian Miranda, MD, Children’s Hospital of WisconsinNader Youssef, MD, Atlantic Health System, Morristown, NJ
EVALUATING NEONATAL LIVER FAILURE Moderator: Grzegorz Telega, MDRobert Squires, MD, Children’s Hospital of PittsburghNada Yazigi, MD, Cincinnati Children’s Hospital Medical Center
POLYPS AND POLYPOSIS SYNDROMESModerator: Steven Erdman, MDThomas Attard, MD, University of NebraskaSherry Huang, MD, UC-San DiegoCarol Durno, MD, Mt. Sinai Hospital, Toronto
HOW BEST TO TREAT NONACID REFLUX?Moderator: Judith O’Connor, MDHayat Mousa, MD, Nationwide Children’s Hospital, Columbus OHRachel Rosen, MD, Children’s Hospital, Boston
MANAGING COMPLICATIONS OF GERD Moderator: David Gremse, MDEric Hassall, MD, University of British Columbia Vasu Tolia, MD, Pediatric GI Center, Detroit
MANAGING GI COMPLICATIONS OF CYSTIC FIBROSISModerator: Ashish Patel, MDJohn Pohl, MD, Scott and White Hospital, Temple, TXSarah Jane Schwarzenberg, MD, Minnesota Children’s Hospital
BILIARY DISEASE: STONES AND GROANS IN THE UPPER RIGHT QUADRANT Moderator: Miguel Saps, MDJames Heubi, MD, Cincinnati Children’s Hospital Medical Center Sonia Michail, MD, Children’s Medical Center, Dayton
METABOLIC LIVER DISEASE: WHEN TO CONSIDER THE DIAGNOSIS & HOW TO MAKE ITModerator: Shikha Sundaram, MDBinita Kamath, MD, Children’s Hospital of PhiladelphiaSaul Karpen, MD, Texas Children’s Hospital
REFRACTORY CONSTIPATION: WHERE DOES IT STOP?Moderator: Bankole Osuntokun, MDRina Sanghavi, MD, Children’s Medical Center, DallasManu Sood, MD Children’s Hospital of Wisconsin
1
2
3
14 Saturday, November 14, 2008 continued . . .
�
�
�
�
�
�
1:30pm–3:00pm CONCURRENT SESSION V
INFLAMMATORY BOWEL DISEASE (IBD) – CLINICAL SCENARIOS: HOW DO YOU TREAT? Moderators: Paul Rufo, MD and Maria Oliva Hemker, MD
How do we manage a patient with IBD until mercaptopurines becomes therapeutic? William Faubion, MD, Mayo Clinic, Rochester
Learning Objectives: 1. Review thiopurine metabolism and current therapeutic monitoring2. Identify bridging treatment approaches3. Discuss complications of use of thiopurines (pancreatitis, lymphoma, infection)
How do we best manage the patient with refractory Crohn disease? Ted Denson, MD, Cincinnati Children’s Hospital Medical Center
Learning Objectives: 1. Define the “refractory Crohn” patient, including “steroid-dependent” and “resistant”2. Describe the use of methotrexate and infliximab for treatment of refractory patients3. Review the therapeutic options for steroid-refractory hospitalized patient
(cyclosporine, tacrolimus, infliximab, surgery)4. Review the rescue therapies in those failing to respond to biologics (adalimumab,
thalidomide)
How do we best manage the patient with refractory ulcerative colitis? Athos Bousvaros, MD, Children’s Hospital, Boston
Learning Objectives: 1. Define the “refractory UC” patient2. Describe the use of methotrexate and infliximab for treatment of refractory patients3. Review the therapeutic options for steroid-refractory hospitalized patient
(cyclosporine, tacrolimus, infliximab, surgery)4. Review the rescue therapies in those failing to respond to biologics (adalimumab,
thalidomide)
ANTIBIOTIC THERAPY IN GASTROINTESTINAL DISEASE: WHAT’S THE EVIDENCE? Moderators: John Udall, MD and Mary Zachos, MD
Antibiotics and Inflammatory Bowel Disease (IBD) Anne Griffiths, MD, The Hospital for Sick Children, Toronto
Learning Objectives: 1. Review the use of antibiotics as initial therapy and for perianal disease in IBD2. Characterize the evidence base for antibiotic use in fistula and stricture formation3. Describe the evidence for usage of pre- / probiotics for treatment of IBD
Antibiotics and irritable bowel syndrome (IBS) Mark Pimentel, MD, Cedars Sinai Medical Center
Learning Objectives: 1. Describe the pathophysiology of post-infectious IBS2. Identify antibiotic regimens currently being studied in the treatment of IBS3. Discuss the evidence for use of pre- / probiotics for treatment of IBS
Clostridium difficile: How do you treat the patient with relapsing disease? Michael Farrell, MD, Cincinnati Children's Hospital Medical Center
Learning Objectives: 1. Define the incidence of relapsing C. difficile infections in hospitalized patients2. Identify the current effective antibiotic regimens for relapsing C. difficile infection3. Discuss non-antibiotic regimens, including probiotics, IVIG, and cholestyramine
ORAL ABSTRACT PRESENTATIONS
15
1
2
3
�
�
�
3:15pm–4:45pm CONCURRENT SESSION VI
BILLING AND CODING 101, 102 Moderators: Leo Heitlinger, MD and Roxanne Hecht, MD
Kathleen Mueller, McVey AssociatesLearning Objectives: 1. Describe billing codes for new endoscopic procedures2. Describe billing codes for newly established gastrointestinal disease3. Provide examples of complex patients that would stimulate mulitple billing codes
EDUCATION 2008: IS SIMULATION THE NEW WAVE?Moderator: B Li, MD
Laurie Fishman, MD, Alan Leichtner, MD and Jeffrey Burns, MD, Children's Hospital BostonLearning Objectives: 1. Review the use of simulation in the context of adult learning principles2. Identify endoscopic simulation products and studies that evaluate competence3. Discuss application of simulation techniques to training in pediatric gastroenterology
RESEARCH MENTORING, CAREER DEVELOPMENT AND METHODOLOGY WORKSHOP Moderators: Mitchell Cohen, MD and David Rudnick, MD, PhD
Pat Robuck, PhD, MPH, D. Brent Polk, MD, PhD and Rob Squires, MDLearning Objectives: 1. Review current NIH and non-NIH funding opportunities for junior faculty2. Discuss career development strategies for both basic and clinical/translational faculty 3. Interactive question & answer session for both basic, clinical/translational research faculty
5:00pm BUSINESS MEETING – NASPGHAN/CDHNF AWARDS CEREMONY
7:00pm CDHNF 1OTH ANNIVERSARY CELEBRATION DINNER
NASPGHAN/CDHNF Conference / November 13–15, 2008 / San Diego, California
Registration FormRegistration Deadline: October 14, 2008
After October 14, fees for the NASPGHAN/CDHNF Conference and the Single Topic Symposium will increase by $50 per category
Register on-line at www.naspghan.org (please print clearly)
First Name Last Name
Address
City State Zip Country
Phone Fax
Email (very important)
SINGLE TOPIC SYMPOSIUM – THE GUT MICROBIOME IN DEVELOPMENT, HEALTH & DISEASE Wednesday, November 12, 2008
CHECK YOUR MEMBER TYPE FEE AMOUNT OWED
Member A $100
Non-member B $175
Trainee/Fellow Member C $50
APGNN Member D $50
Non-Member Nurse E $75
Non-Member Trainee F $75
NASPGHAN–CDHNF CHALLENGES IN NUTRITION POSTGRADUATE COURSEThursday, November 13, 2008
CHECK YOUR MEMBER TYPE FEE AMOUNT OWED
Member G $275
Non-member H $375
Trainee/Fellow Member I $175
APGNN Member J $175
Non-Member Nurse K $225
Non-Member Trainee L $225
CHECK YOUR MEMBER TYPE FEE AMOUNT OWED
Member N $300
Non-member O $400
Trainee/Fellow Member P $200
APGNN Member Q $200
Non-Member Nurse R $250
Non-Member Trainee S $250
Student / Resident T $50
NASPGHAN – CDHNF NUTRITION LEARNING LUNCHES (SELECT ONE)Thursday, November 13, 2008 You must be registered for the Challenges in Nutrition Postgraduate Course to attend a Learning Lunch
�
�
�
ADDITIONAL Saturday, November 15, 2008
ADDITIONAL – INDICATE CHOICES FEE AMOUNT OWED
Billing and Coding 101, 102 V No Charge
Extra Tickets for Saturday CDHNFDinner Celebration – Adults W $75
Extra Tickets for Saturday CDHNFDinner Celebration – Child X $20
Additional Registration Information�
NASPGHAN – CDHNF CONFERENCE NOVEMBER 13–15, 2008
SEE PAGE 6 FOR TITLES $50 (INDICATE CHOICE) AMOUNT OWED
First Choice M
Second Choice M
Third Choice M
NEW CLINICAL CHALLENGE LUNCHEONS (SELECT ONE)Saturday, November 15, 2008 You must be registered for the NASPGHAN/CDHNFConference to attend a Clinical Challenge Luncheon
GRAND TOTAL $
SEE PAGE 13 FOR TITLES $50 (INDICATE CHOICE) AMOUNT OWED
First Choice U
Second Choice U
Third Choice U
16
What’s included:Single Topic Symposium– Registration fees include continental breakfast and lunch on Wednesday, coffee breaks, and the program book.
NASPGHAN–CDHNF Challenges in Nutrition Postgraduate Course– Registration fees include Postgraduate course syllabus, continental breakfast, and coffee breaks.
NASPGHAN–CDHNF Conference– Registration fees for the Conference include the wine and cheese reception on Thursday evening, lunch on Friday, continental breakfast on Saturday morning, coffee breaks, the CDHNF Dinner Celebration on Saturday evening and the meeting program.
Cancellation and Refund:Requests for refunds must be submitted in writing and be received in the National Office by October 17, 2008. No refund requests will be accepted after that date. Registration badge and receipt must accompany request. Approved refunds will be issued after the meeting.
Payment Information:MasterCard Visa American Express
Credit Card #:__________________________________ Verification Code #:_______ Expiration Date:_____________
Make checks (drawn on a US bank in US funds) payable to NASPGHAN:Mail or Fax completed form to:NASPGHANPO Box 6, Flourtown, PA 19031Fax: 215.233.3918
Contact NASPGHAN National Office for further information:Phone: 215.233.0808 Fax: [email protected] www.naspghan.org
NASPGHAN ID 84–126–4996
NASPGHAN/CDHNF Conference / November 13–15, 2008 / San Diego, California
�
�
�
�